Gsa Capital Partners LLP Boston Scientific Corp Transaction History

Gsa Capital Partners LLP

$1.2 Billion
Q3 2025

A detailed history of Gsa Capital Partners LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 19,035 shares of BSX stock, worth $1.95 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

19,035

Previous 3,348 468.55%

Holding current value

$1.95 Million

Previous $360,000 416.11%

% of portfolio

0.15%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$97.03 - $108.14 $1.52 Million - $1.7 Million	15,687 Added 468.55%	19,035 $1.86 Million
Q2 2025 Jul 22, 2025	SELL	$89.7 - $107.41 $69,966 - $83,779	-780 Reduced 18.9%	3,348 $360,000
Q1 2025 May 08, 2025	BUY	$89.38 - $106.18 $74,096 - $88,023	829 Added 25.13%	4,128 $416,000
Q4 2024 Feb 07, 2025	BUY	$83.62 - $91.5 $275,862 - $301,858	3,299 New	3,299 $295,000
Q2 2022 Aug 09, 2022	BUY	$35.24 - $47.1 $675,973 - $903,472	19,182 New	19,182 $715,000

Q4 2020 Feb 03, 2021	SELL	$33.15 - $41.97 $249,652 - $316,076	-7,531 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$34.44 - $42.23 $4,959 - $6,081	-144 Reduced 1.88%	7,531 $288,000
Q2 2020 Aug 11, 2020	BUY	$30.19 - $39.11 $231,708 - $300,169	7,675 New	7,675 $269,000
Q1 2020 May 12, 2020	SELL	$25.83 - $45.71 $238,152 - $421,446	-9,220 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$37.87 - $45.37 $213,814 - $256,159	-5,646 Reduced 37.98%	9,220 $417,000
Q3 2019 Nov 12, 2019	BUY	$40.31 - $43.45 $599,248 - $645,927	14,866 New	14,866 $605,000
Q2 2019 Aug 06, 2019	SELL	$34.91 - $42.98 $556,989 - $685,745	-15,955 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $22,576 - $27,954	-686 Reduced 4.12%	15,955 $612,000
Q4 2018 Feb 12, 2019	BUY	$31.73 - $39.04 $528,018 - $649,664	16,641 New	16,641 $588,000
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $355,811 - $418,671	-10,838 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$26.84 - $34.32 $49,090 - $62,771	-1,829 Reduced 14.44%	10,838 $354,000
Q1 2018 May 11, 2018	SELL	$25.2 - $28.54 $2.27 Million - $2.57 Million	-90,193 Reduced 87.69%	12,667 $346,000
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $2.55 Million - $3.07 Million	102,860	102,860 $2.55 Million

Others Institutions Holding BSX

# of Institutions

1,953

Shares Held

1.26B

Call Options Held

10.9M

Put Options Held

8.94M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Boston Scientific Corp Transaction History